Top Tweets for #METALD
📢 New Review in @LiversMDPI
🧬 Stem et al. examine fructose–alcohol interactions in MetALD.
🩺 Pathways include mitochondrial dysfunction, lipid metabolism, and gut–liver axis disruption.
📖 Read More: https://t.co/2LsNSB5Bn9
#MetALD #Fructose #Hepatotoxicity
Esta tarde tendré ocasión de debatir con @rabataller y JP Arab sobre #MetALD en el webinar @AEEHLiver
En mi caso, visión desde la experiencia en #MASLD
Inscripción gratuita, no te lo pierdas!
@sepdigestiva @sapdes @ibis_sevilla @HospitalUVRocio @unisevilla @sociedadSEEN
@MetabolismAnd @LiverDiseaseJp @livercaretips @liverdiseases @endliverdisease @SaudiLiver @LiverDiseaseSup @LD_P2P @hepinternation1 @_atanas_ @HazemAbosheaish The pre-transplant window seems crucial here—do we know which intervention most consistently improves outcomes in MetALD, abstinence support, weight loss, or combined programs? Sci-Quest generates biomedical literature reviews too: https://t.co/AMUYFvZ8PU #MetALD
This review highlights the challenges of MetALD before and after liver transplantation, including higher risks of waitlist deterioration, mortality, and graft failure.
🔗 https://t.co/DNpCGJno2i
#MetALD #LiverTransplantation #MASLD #LiverDisease
Read "Long-Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD-ALD Prediction Index" just published online at https://t.co/GQ2D7faYVX
#livertwitter #MetALD
🟣Phosphatidylethanol improves diagnostic accuracy of #MASLD, #MetALD, and #ALD: Results from a prospective cohort study
🔓#OpenAccess at👉https://t.co/eMRGhn4m0P
#MASLD #MetALD #ALD #LiverTwitter #LiverHealth #LiverX
Integrated management of MetALD requires addressing both alcohol use and cardiometabolic risk, with emerging pharmacologic therapies offering potential options for selected patients.
Read more: https://t.co/zPQ2oi7aWP
#MetALD #LiverDisease #Pharmacotherapy #MTODJournal
📢 New Editorial in #eGastroenterology
🔄 Dr Lanlan Chen, Dr Paul Horn and Prof. Frank Tacke highlight that #MASLD, #MetALD and #ALD should be viewed as a dynamic continuum rather than static diagnostic labels.
🎯 Longitudinal reassessment, objective alcohol measurement and fibrosis-based risk stratification could better reflect disease trajectories and guide personalised management.
🔗 Explore the article: https://t.co/stqDPQs5x5
#LiverDisease #SteatoticLiverDisease #Hepatology #AlcoholRelatedLiverDisease
@SighPichamol, MD, from @BrighamWomens, discusses endoscopic bariatric therapies for #MetALD, an etiology of #LiverDisease with growing incidence and limited treatments. #MASLD #Hepatology
📹 Watch the full interview here:
https://t.co/YsCL0fiw1S
📢 New Editorial in #eGastroenterology
🔄 Dr Lanlan Chen, Prof. Frank Tacke and their team, from Charité – Universitätsmedizin Berlin, Germany, reframe #MASLD, #MetALD and #ALD as an evolving continuum rather than fixed diagnoses.
🧭 Tracking alcohol exposure, metabolic health and liver fibrosis over time—supported by tools such as PEth—could improve risk stratification and personalised care. #SteatoticLiverDisease #Hepatology
🔗 Explore the article: https://t.co/stqDPQs5x5
@LanlanChen10 @Tacke_lab @Gut_BMJ @BMJOpen_Gastro @BMJ_Open @FrontGastro_BMJ
📑 Clinical outcomes in #MetALD compared with #ALD in patients referred for liver transplant evaluation❕
#OpenAccess #LiverX
https://t.co/Jba504AVnm
This review summarizes current evidence showing that treatment must combine alcohol-use control with cardiometabolic therapies, including incretin-based agents and nuclear receptor modulators, while emphasizing the lack of dedicated MetALD trials.
https://t.co/zPQ2oi7aWP
#MetALD
👁️¿Has echado un vistazo a nuestro nuevo 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐚 𝐅𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐨 𝐀𝐄𝐄𝐇 𝟐𝟎𝟐𝟔/𝟐𝟎𝟐𝟕?
✅¡Se avecinan temas muy interesantes!
🗓️Próximo webinar, en septiembre. "#MetALD: revisión del concepto, mecanismos fisiopatológicos y abordaje".
🔎¡Te lo contamos todo en la web!: ➡️
https://t.co/zglgKcLVN6
This review highlights the lack of dedicated trials and supports an integrated strategy combining alcohol-use management with cardiometabolic therapies, including incretin-based and nuclear receptor–targeting agents.
https://t.co/zPQ2oi7aWP
#MetALD #LiverDisease #Pharmacotherapy
Last Seen Hashtags on Sotwe
Humiliation
Seen from Turkey
snapchat()******************* filter:native_video(***)
Seen from Malaysia
dogsex filter:videos
minichat (((***)))** filter:videos
Seen from United States
unSea活
Seen from Japan
anxiouspanda()() () () () () +filter:native_video
سكس_يمني
Seen from France
ChristmasSpirit
Seen from United States
incest
فرشته_علیزاده
Seen from United States
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.6M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers